Science & Resouces | MLife

Specs

2 ¾” w x 3 ½” h x ¾” d

Weighs less than 2 oz.

View Panel Levels

Watch our instructional video on how to use the mLife Verify device.

Visual Interpretation of mLife Verify Results

Negative:
• Two lines appear. One line visible in the control region (C), and another line visible in the test region (T).
• This indicates the drug concentration is below the detectable level.

Positive:
• One line appears in the control region (C). No line appears in the test region (T).
• The lack of a line in the test region (T) indicates a presumptive positive result for the corresponding drug of that specific test region.

Invalid:
• Control line fails to appear.
• Insufficient specimen volume or incorrect procedural techniques are the most likely reason for control line failure.

Interpretation of Results_mLife_Oral Sal

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs

Efforts to control SARS-CoV-2, the novel coronavirus causing COVID-19 pandemic, dependon accurate and rapid diagnostic testing. These tests must be ( 1 ) sensitive to mild andasymptomatic infections to promote effective self isolation and reduce transmission withinhigh risk groups 1; ( 2 ) consistent to reliably monitor disease progression and aid clinicaldecisions 2; and ( 3 ) scalable to inform local and national public health policies, such as when
social distancing measures can be safely relaxed.

Read White Paper

Consistent Detection of 2019 Novel
Coronavirus in Saliva

The 2019 novel coronavirus (2019-nCoV) was detected in the
self-collected saliva of 91.7% (11/12) of patients. Serial saliva
viral load monitoring generally showed a declining trend. Live
virus was detected in saliva by viral culture. Saliva is a promising
noninvasive specimen for diagnosis, monitoring, and infection
control in patients with 2019-nCoV infection.

Read White Paper

Drug use and abuse are critical social issues in the United States in 2018. Two drug families in particular stand out: marijuana (cannabinoids) and opioids.

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs

View Full Report